GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » XCounter AB (OSTO:XCT) » Definitions » Capex-to-Revenue

XCounter AB (OSTO:XCT) Capex-to-Revenue : 0.05 (As of Dec. 2012)


View and export this data going back to . Start your Free Trial

What is XCounter AB Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

XCounter AB's Capital Expenditure for the three months ended in Dec. 2012 was kr-0.92 Mil. Its Revenue for the three months ended in Dec. 2012 was kr19.56 Mil.

Hence, XCounter AB's Capex-to-Revenue for the three months ended in Dec. 2012 was 0.05.


XCounter AB Capex-to-Revenue Historical Data

The historical data trend for XCounter AB's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XCounter AB Capex-to-Revenue Chart

XCounter AB Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only - 0.05 - 0.08 0.02

XCounter AB Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12
Capex-to-Revenue 0.19 0.02 0.31 -0.33 0.05

Competitive Comparison of XCounter AB's Capex-to-Revenue

For the Medical Devices subindustry, XCounter AB's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


XCounter AB's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, XCounter AB's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where XCounter AB's Capex-to-Revenue falls into.



XCounter AB Capex-to-Revenue Calculation

XCounter AB's Capex-to-Revenue for the fiscal year that ended in Dec. 2012 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1.675) / 74.135
=0.02

XCounter AB's Capex-to-Revenue for the quarter that ended in Dec. 2012 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.923) / 19.563
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


XCounter AB  (OSTO:XCT) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


XCounter AB Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of XCounter AB's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


XCounter AB (OSTO:XCT) Business Description

Traded in Other Exchanges
N/A
Address
Website

XCounter AB (OSTO:XCT) Headlines

No Headlines